Frequently asked questions.

What are the top focus areas for the SITRAVON EXECUTIVE team?

  • Increasing Internal Return Rate on Research & Development

  • Decreasing Dead End R&D Projects

  • Decreasing Costs to Bring Assets to Market

  • Accurately Forecasting / Driving Global Sales

  • Decreasing Cycle Time to Market

  • Identify Profitable Pipelines Over Next 5 Years

WHY was there a focus on acquiring other companies and technologies in the past several years?

Sitravon has a commitment to significantly increasing the therapeutic pipeline, decreasing the time to market, driving digital transformation, leverage new technologies, and increase cost efficiencies throughout the company. To deliver maximum value to our shareholders we desire to “do more by spending less.”

How Should Vendors approach selling to Sitravon?

All vendors should garner a “sponsor” that resides inside the “Sitravon Inner Circle” - all organized under the Sitravon Corporate layer. These executives are responsible for the corporate vision, the company’s values and their method of execution to maintain superiority in the marketplace. Any and all purchasing decisions over $50,000 need to secure a “sponsor.”

What are some of the top corporate concerns for the executive team?

  • Attracting / Retaining Top Talent

  • Developing the Next Generation of Leaders

  • Digital Transformation

  • Driving New Product Innovation

  • Outperforming Key Competitors (Speed to Market)

What are some of the key focus areas regarding technology within the company?

The big area is streamlining technology to achieve the company's operational goals. This includes harmonizing technological solutions with the organization's daily operations, with a primary focus on improving the efficiency of laboratory processes, clinical trials, and regulatory compliance to achieve tangible business outcomes.

What are two areas the company is leveraging innovation to be a market leader?

Data-Driven Innovation and Research: Leveraging data analytics, artificial intelligence, and machine learning to enhance the research and development processes. This involves using digital technologies to streamline drug discovery, clinical trials, and the analysis of scientific data. Also lead initiatives to implement advanced data analytics tools, develop predictive models, and harness big data to accelerate research and optimize outcomes.

Patient-Centric Digital Healthcare: Focusing on patient engagement and outcomes by implementing digital healthcare solutions. Focus to improve patient experiences, remote monitoring, and personalized medicine through digital technologies